SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Divis Lab spurts on reporting 52% rise in Q3 net profit

04 Feb 2014 Evaluate

Divis Laboratories is currently trading at Rs. 1370.05, up by 56.90 points or 4.33 % from its previous closing of Rs. 1313.15 on the BSE.

The scrip opened at Rs. 1365.00 and has touched a high and low of Rs. 1388.00 and Rs. 1350.00 respectively. So far 38004 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1388.00 on 04-Feb-2014 and a 52 week low of Rs. 905.00 on 05-Aug-2013.

Last one week high and low of the scrip stood at Rs. 1344.65 and Rs. 1239.00 respectively. The current market cap of the company is Rs. 18197.87 crore.

The promoters holding in the company stood at 52.12% while Institutions and Non-Institutions held 29.42% and 18.46% respectively.

Divis Laboratories has reported 51.84% rise in its net profit at Rs 219.02 crore for third quarter ended December 31, 2013 as compared to Rs 144.24 crore for the same quarter in the previous year. Total income of the company increased by 25.24% at Rs 697.18 crore for quarter under review as compared to Rs 556.68 crore for the quarter ended December 31, 2012.

Divis Laboratories, together with its subsidiaries, engaged in the manufacture and sale of active pharma ingredients (APIs) and intermediates for the pharmaceutical industry in India and worldwide.

Divis Lab Share Price

6228.95 -68.55 (-1.09%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×